Molecular Data (MKD) stock price, revenue, and financials

Molecular Data market cap is $188.7 m, and annual revenue was ¥9.05 b in FY 2018

$188.7 M

MKD Mkt cap, 27-May-2020

¥9.1 B

Molecular Data Revenue FY, 2018
Molecular Data Revenue growth (FY, 2017 - FY, 2018), %115%
Molecular Data Gross profit (FY, 2018)80.2 M
Molecular Data Gross profit margin (FY, 2018), %0.9%
Molecular Data Net income (FY, 2018)-254.6 M
Molecular Data EBIT (FY, 2018)-235.8 M
Molecular Data Cash, 30-Sept-201936.9 M
Molecular Data EV168.4 M

Molecular Data Revenue

Molecular Data revenue was ¥9.05 b in FY, 2018 which is a 115.5% year over year increase from the previous period.

Embed Graph

Molecular Data Revenue Breakdown

Embed Graph

Molecular Data revenue breakdown by business segment: 99.9% from Chemical Trading - Direct Sales Model and 0.1% from Other

Molecular Data Income Statement

Annual

CNYFY, 2016FY, 2017FY, 2018

Revenue

3.2b4.2b9.1b

Revenue growth, %

31%115%

Cost of goods sold

3.2b4.2b9.0b

Gross profit

26.1m50.2m80.2m

Gross profit Margin, %

1%1%1%

Sales and marketing expense

59.2m65.0m103.3m

R&D expense

20.1m18.6m36.9m

General and administrative expense

41.8m41.7m173.9m

Operating expense total

131.9m141.4m316.0m

EBIT

(105.8m)(91.2m)(235.8m)

EBIT margin, %

(3%)(2%)(3%)

Interest expense

8.4m16.8m19.0m

Pre tax profit

(113.9m)(107.8m)(254.6m)

Net Income

(113.9m)(107.8m)(254.6m)

Molecular Data Balance Sheet

Annual

CNYFY, 2017FY, 2018

Cash

38.5m6.5m

Accounts Receivable

53.9m40.7m

Prepaid Expenses

1.1m1.7m

Inventories

19.2m7.3m

Current Assets

376.5m367.7m

PP&E

2.7m1.8m

Total Assets

381.1m371.6m

Accounts Payable

67.0m49.3m

Short-term debt

138.6m82.0k

Current Liabilities

299.9m255.4m

Non-Current Liabilities

75.4m177.8m

Total Debt

138.6m82.0k

Total Liabilities

375.2m433.2m

Common Stock

98.0k98.0k

Additional Paid-in Capital

311.5m498.6m

Retained Earnings

(305.7m)(560.3m)

Total Equity

5.9m(61.6m)

Debt to Equity Ratio

23.5 x0 x

Debt to Assets Ratio

0.4 x0 x

Financial Leverage

64.6 x-6 x

Quarterly

CNYQ3, 2019

Cash

36.9m

Accounts Receivable

26.8m

Prepaid Expenses

243.0k

Inventories

3.9m

Current Assets

375.0m

PP&E

1.2m

Total Assets

381.0m

Accounts Payable

155.2m

Short-term debt

16.3m

Current Liabilities

374.1m

Long-term debt

273.0k

Non-Current Liabilities

171.0m

Total Debt

16.6m

Total Liabilities

545.1m

Common Stock

98.0k

Additional Paid-in Capital

529.4m

Retained Earnings

(693.6m)

Total Equity

(164.1m)

Financial Leverage

-2.3 x

Molecular Data Cash Flow

Annual

CNYFY, 2016FY, 2017FY, 2018

Net Income

(113.9m)(107.8m)(254.6m)

Depreciation and Amortization

978.0k1.5m2.4m

Accounts Receivable

(44.7m)15.2m13.4m

Inventories

(14.8m)(3.2m)11.9m

Accounts Payable

33.1m(26.5m)14.0m

Cash From Operating Activities

(145.6m)(186.7m)(134.6m)

Purchases of PP&E

(2.6m)(537.0k)(484.0k)

Cash From Investing Activities

(2.6m)(4.0m)(2.2m)

Long-term Borrowings

(633.4m)(984.5m)(833.2m)

Cash From Financing Activities

173.3m262.8m37.3m

Net Change in Cash

25.1m72.2m(99.5m)

Interest Paid

(8.5m)(17.0m)(19.4m)

Quarterly

CNYQ3, 2018Q3, 2019

Net Income

(88.0m)(133.2m)

Depreciation and Amortization

1.3m2.4m

Accounts Receivable

2.7m11.4m

Inventories

10.6m3.3m

Accounts Payable

10.2m65.6m

Cash From Operating Activities

(53.4m)(33.4m)

Purchases of PP&E

(298.0k)(730.0k)

Cash From Investing Activities

(1.3m)(1.7m)

Long-term Borrowings

(748.7m)

Cash From Financing Activities

21.2m104.5m

Net Change in Cash

(33.6m)69.4m

Interest Paid

(15.2m)(2.9m)

Molecular Data Ratios

CNYY, 2019

EV/CFO

-5 x

Financial Leverage

-2.3 x

Molecular Data Operating Metrics

Molecular Data's New Customers was reported to be 16.6 k in Q3, 2019. Molecular Data's Customers was reported to be 110.9 k in Q3, 2019.
FY, 2016FY, 2017Q3, 2018FY, 2018Q3, 2019

Chemical Compounds

1.38 m7.02 m8.79 m8.79 m10.30 m

Total Number of Transaction Orders

89.71 k110.50 k117.78 k166.14 k119.65 k

Transaction Orders (Direct Sales Model)

31.75 k38.83 k34.20 k50.38 k40.07 k

Transaction Orders (Marketplace Model)

57.96 k71.67 k83.58 k115.75 k79.58 k

Customers

42.65 k65.98 k87.53 k94.37 k110.95 k

Customers (Direct Sales Model)

3.13 k5.38 k7.49 k9.01 k11.12 k

Customers (Marketplace Model)

41.05 k63.41 k84.22 k90.13 k105.58 k

Transacting Customers

20.48 k27.43 k27.96 k35.57 k24.37 k

Transacting Customers (Direct Sales Model)

2.67 k3.44 k3.28 k4.03 k3.24 k

Transacting Customers (Marketplace Model)

19.02 k25.31 k25.93 k32.53 k21.73 k

New Customers

18.26 k23.33 k21.57 k28.39 k16.58 k

Suppliers

28.90 k31.17 k33.30 k33.75 k35.09 k

Suppliers (Direct Sales Model)

2.35 k3.73 k4.78 k5.16 k6.17 k

Suppliers (Marketplace Model)

28.42 k30.28 k31.82 k32.01 k32.68 k

Transacting Suppliers

11.23 k15.79 k15.44 k17.16 k17.42 k

Transacting Suppliers (Direct Sales Model)

1.86 k2.08 k2.04 k2.49 k2.10 k

Transacting Suppliers (Marketplace Model)

9.95 k14.21 k14.01 k15.41 k15.72 k

New Suppliers

6.45 k2.27 k2.13 k2.58 k1.33 k

Users (SaaS Suite)

98 k

Customers Using Financial Solutions

2.20 k